LSBCF (LakeShore Biopharma Co) EPS (Basic): $-0.72 (TTM As of Mar. 2025)


What is LakeShore Biopharma Co EPS (Basic)?

LakeShore Biopharma Co LSBCF EPS (Basic) is $-0.72 as of Mar. 2025. The stock has 5 warning signs investors should review.

LakeShore Biopharma Co's basic earnings per share (Basic EPS) for the six months ended in Mar. 2025 was $-0.87. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was $-0.72.

LakeShore Biopharma Co's EPS (Diluted) for the six months ended in Mar. 2025 was $-0.87. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was $-0.72.

LakeShore Biopharma Co's EPS without NRI for the six months ended in Mar. 2025 was $-0.62. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was -0.47.

During the past 3 years, the average EPS without NRI Growth Rate was 34.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, LakeShore Biopharma Co's highest 3-Year average EPS without NRI Growth Rate was 34.90% per year. The lowest was -5.40% per year. And the median was 14.75% per year.

LakeShore Biopharma Co  (OTCPK:LSBCF) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

LakeShore Biopharma Co EPS (Basic) Related Terms

LakeShore Biopharma Co EPS (Basic) Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co EPS (Basic) Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
EPS (Basic)
-3.47 -4.05 -3.42 -5.63 -0.72

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only -2.11 -2.58 -3.02 0.16 -0.87

LakeShore Biopharma Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

LakeShore Biopharma Co's Basic EPS for the fiscal year that ended in Mar. 2025 is calculated as

Basic EPS (A: Mar. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-13.792-0)/19.159
=-0.72

LakeShore Biopharma Co's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-16.631-0)/19.275
=-0.86

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of $-0.72 mean?
LakeShore Biopharma Co (LSBCF) has a EPS (Basic) of $-0.72 as of Mar. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's EPS (Basic) too high?
LakeShore Biopharma Co's current EPS (Basic) is $-0.72.
How does LakeShore Biopharma Co's EPS (Basic) compare to ACUT and PPCB?
LakeShore Biopharma Co's EPS (Basic) of $-0.72 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current EPS (Basic) is $-0.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current EPS (Basic) of $-0.72. The current EPS (Basic) is $-0.72. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current EPS (Basic) is $-0.72 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.